Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3. 1995

W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
Department of Molecular Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

The common fragile site at 3p14.2 (FRA3B) has been described as the most active fragile site in the human genome. This locus may predispose chromosome 3 to specific losses due to deletions and translocations that have been associated with several malignancies, including hereditary renal cell carcinoma. We have previously described induction of breakage around FRA3B using aphidicolin in a somatic cell hybrid whose only human component was a single intact chromosome 3. That work led to the isolation of hybrids with breakpoints in the 3p13-p21.1 region with loss of all sequences distal to their respective breakpoints. In this report we describe the further characterization of the breakpoints in many of these cell lines using newly available molecular markers. We also report the identification of YAC clones that span the breakpoints present in many of these hybrids.

UI MeSH Term Description Entries
D002873 Chromosome Fragility Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations. Chromosomal Fragility,Fragility, Chromosomal,Fragility, Chromosome
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006822 Hybrid Cells Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION. Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D016590 Aphidicolin An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. Aphidicolin, (3-S-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-Isomer,ICI-69653,NSC-234714,NSC-351140,ICI 69653,ICI69653,NSC 234714,NSC 351140,NSC234714,NSC351140
D043283 Chromosome Fragile Sites Specific loci that show up during KARYOTYPING as a gap (an uncondensed stretch in closer views) on a CHROMATID arm after culturing cells under specific conditions. These sites are associated with an increase in CHROMOSOME FRAGILITY. They are classified as common or rare, and by the specific culture conditions under which they develop. Fragile site loci are named by the letters "FRA" followed by a designation for the specific chromosome, and a letter which refers to which fragile site of that chromosome (e.g. FRAXA refers to fragile site A on the X chromosome. It is a rare, folic acid-sensitive fragile site associated with FRAGILE X SYNDROME.) Fragile Sites, Chromosome,Chromosome Fragile Site,Fragile Site, Chromosome,Site, Chromosome Fragile,Sites, Chromosome Fragile

Related Publications

W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
October 1984, Cancer genetics and cytogenetics,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
June 1977, Human genetics,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
October 1993, Human genetics,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
January 1974, American journal of human genetics,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
January 1984, Zhonghua yi xue za zhi,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
January 2001, Molekuliarnaia biologiia,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
July 1999, Genes, chromosomes & cancer,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
July 2000, Genes, chromosomes & cancer,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
January 1973, Humangenetik,
W Paradee, and C Mullins, and Z He, and T Glover, and C Wilke, and B Opalka, and J Schutte, and D I Smith
June 1992, Genomics,
Copied contents to your clipboard!